SEC Form 4 · accession 0001179110-17-010097
Tempest Therapeutics, Inc. · TPST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas Malley
Director
Period of report
Jun 13, 2017
Accepted (ET)
Jul 5, 2017 · 7:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001544227
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 13, 2017 | A | 7,873 | $0.00 | A | 204,981 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.